Codiak BioSciences, Inc.
CDAKDelisted May 2, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001659352
Codiak BioSciences, Inc. was delisted on May 2, 2023; its insiders filed their last Form 4 on Mar 30, 2023; 27 institutions reported holding it in 13F filings for Q1 2023, worth $1.44M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Codiak BioSciences, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 62 | 1 | 49 | −12 |
| Shares | 13.8M | 2.59K | 11.7M | −2.09M (−15.1%) |
| Value | $86.5M | $16.0K | $33.9M | −$52.6M (−60.8%) |
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Codiak BioSciences, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Laurion Capital Management LP | 313,300 | $902.0K | 0.04% |
| Bank of Montreal | 69,500 | $288.0K | 0.00% |
| Ergoteles LLC | 72,979 | $210.0K | 0.01% |
| Private Advisor Group, LLC | 10,959 | $32.0K | 0.00% |
| Qube Research & Technologies Ltd | 11,284 | $32.0K | 0.00% |
| Pathstone Family Office, LLC | 10,000 | $28.8K | 0.00% |
| UBS Group AG | 616 | $2.00K | 0.00% |
| Credit Suisse AG | 8 | $0 | 0.00% |
| Capital Advisors, Ltd. LLC | 12 | $0 | 0.00% |
Sold out (21)
Institutions that held Codiak BioSciences, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Alaska Permanent Fund Corp | 980,194 | $6.15M |
| Gsa Capital Partners LLP | 101,279 | $635.0K |
| Ikarian Capital, LLC | 52,177 | $328.0K |
| Charles Schwab Investment Management Inc | 40,827 | $256.0K |
| Nuveen Asset Management, LLC | 37,184 | $234.0K |
| Citadel Advisors LLC | 32,045 | $201.0K |
| Trexquant Investment LP | 30,068 | $189.0K |
| Rhumbline Advisers | 13,218 | $83.0K |
| Susquehanna International Group, LLP | 12,208 | $77.0K |
| Mirabella Financial Services LLP | 11,500 | $72.0K |
| Deutsche Bank AG | 9,550 | $60.0K |
| American International Group, Inc. | 7,898 | $50.0K |
| California State Teachers Retirement System | 6,792 | $43.0K |
| Allspring Global Investments Holdings, LLC | 4,008 | $25.0K |
| Amalgamated Bank | 2,589 | $16.0K |
| Legal & General Group Plc | 1,661 | $10.0K |
| Ameritas Investment Partners, Inc. | 1,231 | $8.00K |
| Nisa Investment Advisors, LLC | 1,190 | $7.00K |
| Royal Bank of Canada | 978 | $6.00K |
| Prospera Financial Services Inc | 89 | $1.00K |
| Laurel Wealth Advisors LLC | 100 | $1.00K |
Not filed for Q2 2022 yet (1)
Institutions that held Codiak BioSciences, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Amalgamated Financial Corp. | 2,589 | $16.0K |